Montegriffo V
Br Med J. 2010; 2(5348):35-6.
PMID: 20789884
PMC: 1872117.
DOI: 10.1136/bmj.2.5348.35.
Br Med J. 2010; 1(5336):1003-6.
PMID: 20789736
PMC: 2122873.
Br Med J. 2010; 1(5326):282-3.
PMID: 20789624
PMC: 2123756.
Mah G, Tejani A, Musini V
Cochrane Database Syst Rev. 2009; (4):CD003893.
PMID: 19821316
PMC: 7154320.
DOI: 10.1002/14651858.CD003893.pub3.
DAY M, Rand M
Br J Pharmacol Chemother. 1964; 22:72-86.
PMID: 14126060
PMC: 1703913.
DOI: 10.1111/j.1476-5381.1964.tb01545.x.
METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.
HANS S, KOPELMAN H
Br Med J. 1964; 1(5385):736-9.
PMID: 14102016
PMC: 1815191.
DOI: 10.1136/bmj.1.5385.736.
CLINICAL TRIAL OF 2-GUANIDINOMETHYL (1,4) BENZODIOXAN (COMPOUND 1003).
Peart W, Macmahon M
Br Med J. 1964; 1(5380):398-402.
PMID: 14085967
PMC: 1813365.
DOI: 10.1136/bmj.1.5380.398.
METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.
Luke R, Kennedy A
Br Med J. 1964; 1(5374):27-30.
PMID: 14071629
PMC: 1813017.
HAEMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES.
Dollery C, HARINGTON M, Hodge J
Br Heart J. 1963; 25:670-6.
PMID: 14063015
PMC: 1018049.
DOI: 10.1136/hrt.25.5.670.
[The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
SCHAER H, ZIEGLER W
Klin Wochenschr. 1962; 40:959-62.
PMID: 13976633
DOI: 10.1007/BF01481420.
Treatment of severe hypertension with methyldopa.
Hamilton M, KOPELMAN H
Br Med J. 1963; 1(5324):151-5.
PMID: 13952341
PMC: 2123398.
DOI: 10.1136/bmj.1.5324.151.
Natriuretic and water diuretic effects of guanabenz, a central alpha-2 agonist.
Goldberg M, Gehr M, MacCarthy E
Trans Am Clin Climatol Assoc. 1983; 95:79-85.
PMID: 6679138
PMC: 2279617.
3. Animal experimentation leading to the development of drugs benefiting human beings and animals.
Robinson H
Am J Public Health Nations Health. 1967; 57(9):1613-20.
PMID: 6069074
PMC: 1227693.
DOI: 10.2105/ajph.57.9.1613.
Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).
Vejlsgaard V, Christensen M, Clausen E
Br Med J. 1967; 2(5552):598-600.
PMID: 6025595
PMC: 1842098.
DOI: 10.1136/bmj.2.5552.598.
Methyldopa in hypertension.
Br Med J. 1966; 1(5480):119-20.
PMID: 5901568
PMC: 1843320.
Some aspects of the long-term treatment of severe hypertension with methyldopa.
Hamilton M
Postgrad Med J. 1968; 44(507):66-9.
PMID: 5639232
PMC: 2466477.
DOI: 10.1136/pgmj.44.507.66.
Treatment of hypertension with methyldopa.
Johnson P, KITCHIN A, LOWTHER C, Turner R
Br Med J. 1966; 1(5480):133-7.
PMID: 5322501
PMC: 1843337.
DOI: 10.1136/bmj.1.5480.133.
Effect of antihypertensive drugs on the "intrinsic" heart rate.
Kaldor A, Juvancz P
Br Med J. 1969; 2(5655):486-7.
PMID: 4890523
PMC: 1983399.
DOI: 10.1136/bmj.2.5655.486.
Side effects of hypotensive agents evaluated by a self-administered questionnaire.
Bulpitt C, Dollery C
Br Med J. 1973; 3(5878):485-90.
PMID: 4726158
PMC: 1586624.
DOI: 10.1136/bmj.3.5878.485.
Methyldopa hepatitis. Report of three cases.
Hoyumpa Jr A, Connell A
Am J Dig Dis. 1973; 18(3):213-22.
PMID: 4688573
DOI: 10.1007/BF01071975.
